Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2022 Earnings Call Transcript February 16, 2023
Operator: Good day, and welcome to the Ironwood Pharmaceuticals Q4 and Full Year 2022 Investor Update Conference Call. Today’s call is being recorded. . Thank you. And I would now like to turn the conference over to Matt Roache, Director of Investor Relations. Please go ahead.
Matt Roache: Thank you, Savanna. Good morning, and thanks for joining us for our fourth quarter and full year 2022...
